Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Multivariate analysis evaluating the role of patient and pathological factors on the BRCA1- 3’UTR-variant positivity

From: A germline mutation in the BRCA13’UTR predicts Stage IV breast cancer

Multivariate analysis   p-value OR 95% CI
Age   0.915 1 0.98-1.02
Menopausal status: Post 0.492 1.29 0.62-2.69
Grade 2 0.493 0.83 0.49-1.41
  3 0.145 0.66 0.38-1.16
Stage 2 0.065 1.48 0.98-2.24
  3 0.169 1.41 0.87-2.29
  4 0.018 3.73 1.26-11.07
ER and/or PR status: Positive 0.603 0.88 0.56-1.41